Diying Shen

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

Neil L. Berinstein, A.J. Grillo-López, Christine A. White et al. · Annals of Oncology · 1998 · 520 citations · Full text

Anti-tumor Response, Lymphoid Neoplasia, Hematological Malignancy +10

Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.

A.J. Grillo-López, Christine A. White, C. Varns et al. · PubMed · 1999 · 294 citations

Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis

Shilong Yang, Xiaojun Xu, Yongmin Tang et al. · Cytokine · 2016 · 66 citations

Inflammation, Cytokine, Inflammatory Cytokines +15

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study

Huyong Zheng, Hui Jiang, Shaoyan Hu et al. · Journal of Clinical Oncology · 2021 · 46 citations · Full text